chr8-47799296-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006904.7(PRKDC):​c.10211G>A​(p.Gly3404Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0146 in 1,613,624 control chromosomes in the GnomAD database, including 230 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 20 hom., cov: 32)
Exomes 𝑓: 0.015 ( 210 hom. )

Consequence

PRKDC
NM_006904.7 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.02

Publications

11 publications found
Variant links:
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PRKDC Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to DNA-PKcs deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056900084).
BP6
Variant 8-47799296-C-T is Benign according to our data. Variant chr8-47799296-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 379650.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.012 (1821/152284) while in subpopulation NFE AF = 0.0198 (1348/68026). AF 95% confidence interval is 0.0189. There are 20 homozygotes in GnomAd4. There are 916 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKDCNM_006904.7 linkc.10211G>A p.Gly3404Glu missense_variant Exon 72 of 86 ENST00000314191.7 NP_008835.5 P78527-1
PRKDCNM_001081640.2 linkc.10211G>A p.Gly3404Glu missense_variant Exon 72 of 85 NP_001075109.1 P78527-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKDCENST00000314191.7 linkc.10211G>A p.Gly3404Glu missense_variant Exon 72 of 86 1 NM_006904.7 ENSP00000313420.3 P78527-1

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1822
AN:
152166
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00263
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00589
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.0233
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0198
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.0115
AC:
2866
AN:
248590
AF XY:
0.0111
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.00527
Gnomad ASJ exome
AF:
0.00249
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0238
Gnomad NFE exome
AF:
0.0180
Gnomad OTH exome
AF:
0.00927
GnomAD4 exome
AF:
0.0149
AC:
21794
AN:
1461340
Hom.:
210
Cov.:
30
AF XY:
0.0144
AC XY:
10492
AN XY:
726952
show subpopulations
African (AFR)
AF:
0.00233
AC:
78
AN:
33480
American (AMR)
AF:
0.00572
AC:
256
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
60
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00110
AC:
95
AN:
86256
European-Finnish (FIN)
AF:
0.0257
AC:
1363
AN:
53052
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
0.0172
AC:
19102
AN:
1111856
Other (OTH)
AF:
0.0137
AC:
826
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1210
2421
3631
4842
6052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0120
AC:
1821
AN:
152284
Hom.:
20
Cov.:
32
AF XY:
0.0123
AC XY:
916
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00262
AC:
109
AN:
41554
American (AMR)
AF:
0.00589
AC:
90
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4834
European-Finnish (FIN)
AF:
0.0233
AC:
247
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0198
AC:
1348
AN:
68026
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
94
188
283
377
471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0153
Hom.:
52
Bravo
AF:
0.00980
TwinsUK
AF:
0.0183
AC:
68
ALSPAC
AF:
0.0161
AC:
62
ESP6500AA
AF:
0.00299
AC:
12
ESP6500EA
AF:
0.0194
AC:
162
ExAC
AF:
0.0117
AC:
1412
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0150
EpiControl
AF:
0.0161

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:2
Feb 05, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 12, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
1.0
DANN
Benign
0.26
DEOGEN2
Benign
0.043
T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.54
T;T
MetaRNN
Benign
0.0057
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
1.0
PrimateAI
Benign
0.20
T
REVEL
Benign
0.18
Sift4G
Benign
1.0
T;T
Polyphen
0.0010
B;.
Vest4
0.056
MPC
0.21
ClinPred
0.0024
T
GERP RS
-2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.059
gMVP
0.28
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8178225; hg19: chr8-48711857; API